These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 8976104

  • 1. [Hyperuricosuria and urolithiasis].
    Koide T.
    Nihon Rinsho; 1996 Dec; 54(12):3273-6. PubMed ID: 8976104
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Dec; 53():265-71. PubMed ID: 6938003
    [Abstract] [Full Text] [Related]

  • 7. [Oral purine loading test for latent metabolic disorders of uric acid in patients with calcium containing upper urinary calculi].
    Yoneda K.
    Hinyokika Kiyo; 1992 Aug; 38(8):877-84. PubMed ID: 1414737
    [Abstract] [Full Text] [Related]

  • 8. Hyperuricosuric calcium urolithiasis.
    Moe OW, Xu LHR.
    J Nephrol; 2018 Apr; 31(2):189-196. PubMed ID: 29368300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, Li S, Zeng G.
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [Abstract] [Full Text] [Related]

  • 16. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Apr; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Apr; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 19. Prevention of stone disease.
    Porena M, Guiggi P, Micheli C.
    Urol Int; 2007 Apr; 79 Suppl 1():37-46. PubMed ID: 17726351
    [Abstract] [Full Text] [Related]

  • 20. Urinary stone analysis of 1,000 patients in southern Taiwan.
    Chou YH, Li CC, Wu WJ, Juan YS, Huang SP, Lee YC, Liu CC, Li WM, Huang CH, Chang AW.
    Kaohsiung J Med Sci; 2007 Feb; 23(2):63-6. PubMed ID: 17339167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.